Trials / Conditions / Pancreatic Adenocarcinoma Non-resectable

Pancreatic Adenocarcinoma Non-resectable

9 registered clinical trials studyying Pancreatic Adenocarcinoma Non-resectable — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Onc NCT07481383	Continuity Biosciences, LLC	Phase 1
Active Not Recruiting	Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pa NCT06090916	Jonsson Comprehensive Cancer Center	N/A
Recruiting	PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer NCT05524090	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	—
Active Not Recruiting	FAZA PET/MRI Pancreas NCT04395469	University Health Network, Toronto	N/A
Completed	EUS-RFA for Unresectable Pancreatic Ductal Adenocarcinoma NCT03772756	First People's Hospital of Hangzhou	N/A
Terminated	PEGPH20 Plus Gemcitabine With Radiotherapy in Patients With Localized, Unresectable Pancreatic Cancer NCT02910882	Scripps Health	Phase 2
Completed	EUS-Guided Cryothermal Ablation in Patients With Stage III Pancreatic Adenocarcinoma (HybridTherm Study) NCT02336672	IRCCS San Raffaele	N/A
Completed	A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic Adenocarcinoma NCT01677962	Medical University of South Carolina	Phase 1
Completed	Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorec NCT01053013	The Rogosin Institute	Phase 2